Five host analysts from BMO’s 5th Annual Prescriptions for Success Healthcare Conference explore their key takeaways related to multiple value drivers across the healthcare industry along with evolving dynamics from COVID-19, which they gleaned from fireside chats and presentations, as well as moderated panels with several thought leaders. This year, the conference was held in a virtual setting, and similar to prior years, it was highlighted by discussions with senior executives from almost 60 leading companies across the pharmaceutical, biotechnology, and healthcare services sectors. The companies spanned the globe and market capitalization spectrum. The conference also featured a keynote discussion with Dr. Eric Feigl-Ding, a leading epidemiologist and health economist, a physician panel on atopic dermatitis and psoriasis, and a conversation with an expert on health insurance trends.

In addition to discussing industry- and company-specific themes and broader sector insights, Gary Nachman (Specialty Pharmaceuticals analyst), Matt Luchini/George Farmer/ Do Kim (Biotechnology analysts), and Matt Borsch (Managed Care & Healthcare Services analyst) also discuss companies within their respective coverage universes that may be best positioned to outperform over the longer term based on these insights.

To access our full disclosures, please visit: https://researchglobal0.bmocapitalmarkets.com/public-disclosure/